Casdin Capital, LLC 13D and 13G filings for Standard BioTools Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-04 7:46 pm Purchase |
2025-02-28 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 80,864,315 21.600% |
7,098,241 (+9.62%) |
Filing |
| 2024-08-14 8:54 pm Purchase |
2024-08-12 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 73,766,074 19.770% |
3,364,737 (+4.78%) |
Filing |
| 2024-06-03 5:20 pm Sale |
2024-05-30 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 70,401,337 18.910% |
-5,936,401 (-7.78%) |
Filing |
| 2024-05-22 4:54 pm Purchase |
2024-05-17 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 76,337,738 20.370% |
1,802,072 (+2.42%) |
Filing |
| 2024-03-20 5:25 pm Purchase |
2024-03-18 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 74,535,666 19.250% |
9,238,070 (+14.15%) |
Filing |
| 2024-01-09 5:13 pm Purchase |
2024-01-05 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 65,297,596 19.710% |
27,715,250 (+73.75%) |
Filing |
| 2022-04-08 5:07 pm Purchase |
2022-04-04 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 37,582,346 32.740% |
37,582,346 (New Position) |
Filing |